UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 317

Sortiert nach

Adipose Tissue Invariant NKT Cells Protect against Diet-Induced Obesity and Metabolic Disorder through Regulatory Cytokine Production

Immunity (Cambridge, Mass.), 2012-09, Vol.37 (3), p.574-587

2012

Volltextzugriff (PDF)

Androgen Receptor Gene Expression in Prostate Cancer Is Directly Suppressed by the Androgen Receptor Through Recruitment of Lysine-Specific Demethylase 1

Cancer cell, 2011-10, Vol.20 (4), p.457-471

2011

Volltextzugriff (PDF)

Intratumoral androgen biosynthesis in prostate cancer pathogenesis and response to therapy

Endocrine-related cancer, 2011-10, Vol.18 (5), p.R175-R182

2011

Volltextzugriff (PDF)

Redirecting abiraterone metabolism to fine-tune prostate cancer anti-androgen therapy

Nature (London), 2016-05, Vol.533 (7604), p.547-551

2016

Volltextzugriff (PDF)

Chromatin binding of FOXA1 is promoted by LSD1-mediated demethylation in prostate cancer

Nature genetics, 2020-10, Vol.52 (10), p.1011-1017

2020

Volltextzugriff (PDF)

SOX9 drives WNT pathway activation in prostate cancer

The Journal of clinical investigation, 2016-05, Vol.126 (5), p.1745-1758

2016

Volltextzugriff (PDF)

Enhancer RNAs participate in androgen receptor-driven looping that selectively enhances gene activation

Proceedings of the National Academy of Sciences - PNAS, 2014-05, Vol.111 (20), p.7319-7324

2014

Volltextzugriff (PDF)

EZH2 Oncogenic Activity in Castration-Resistant Prostate Cancer Cells Is Polycomb-Independent

Science (American Association for the Advancement of Science), 2012-12, Vol.338 (6113), p.1465-1469

2012

Volltextzugriff (PDF)

ATM Loss Confers Greater Sensitivity to ATR Inhibition than PARP Inhibition in Prostate Cancer

Cancer research (Chicago, Ill.), 2020-06, Vol.80 (11), p.2094-2100

2020

Volltextzugriff (PDF)

Rapid Induction of Androgen Receptor Splice Variants by Androgen Deprivation in Prostate Cancer

Clinical cancer research, 2014-03, Vol.20 (6), p.1590-1600

2014

Volltextzugriff (PDF)

Adoptive Transfer of Invariant NKT Cells as Immunotherapy for Advanced Melanoma: A Phase I Clinical Trial

Clinical cancer research, 2017-07, Vol.23 (14), p.3510-3519

2017

Volltextzugriff (PDF)

Targeting the androgen receptor and overcoming resistance in prostate cancer

Current opinion in oncology, 2019-05, Vol.31 (3), p.175

2019

Volltextzugriff (PDF)

WNT5a Signaling through ROR2 Activates the Hippo Pathway to Suppress YAP1 Activity and Tumor Growth

Cancer research (Chicago, Ill.), 2023-04, Vol.83 (7), p.1016-1030

2023

Volltextzugriff (PDF)

Androgen receptor and MYC equilibration centralizes on developmental super-enhancer

Nature communications, 2021-12, Vol.12 (1), p.7308-7308, Article 7308

2021

Volltextzugriff (PDF)

Expression of PD-L1 in Hormone-naïve and Treated Prostate Cancer Patients Receiving Neoadjuvant Abiraterone Acetate plus Prednisone and Leuprolide

Clinical cancer research, 2017-11, Vol.23 (22), p.6812-6822

2017

Volltextzugriff (PDF)

Androgen Receptor Tumor Suppressor Function Is Mediated by Recruitment of Retinoblastoma Protein

Cell reports (Cambridge), 2016-10, Vol.17 (4), p.966-976

2016

Volltextzugriff (PDF)

Galeterone Prevents Androgen Receptor Binding to Chromatin and Enhances Degradation of Mutant Androgen Receptor

Clinical cancer research, 2014-08, Vol.20 (15), p.4075-4085

2014

Volltextzugriff (PDF)

Role of Androgen Receptor Variants in Prostate Cancer: Report from the 2017 Mission Androgen Receptor Variants Meeting

European urology, 2018-05, Vol.73 (5), p.715-723

2018

Volltextzugriff (PDF)

Abiraterone treatment in castration-resistant prostate cancer selects for progesterone responsive mutant androgen receptors

Clinical cancer research, 2015-03, Vol.21 (6), p.1273-1280

2015

Volltextzugriff (PDF)

Castration-resistant prostate cancer: Adaptive responses in the androgen axis

Cancer treatment reviews, 2014-04, Vol.40 (3), p.426-433

2014

Volltextzugriff (PDF)

Lysine-specific demethylase 1 has dual functions as a major regulator of androgen receptor transcriptional activity

Cell reports (Cambridge), 2014-12, Vol.9 (5), p.1618-1627

2014

Volltextzugriff (PDF)

Association Between Androgen Receptor Splice Variants and Prostate Cancer Resistance to Abiraterone and Enzalutamide

Journal of clinical oncology, 2017-07, Vol.35 (19), p.2103-2105

2017

Volltextzugriff (PDF)

Androgen Receptor Serine 81 Phosphorylation Mediates Chromatin Binding and Transcriptional Activation

The Journal of biological chemistry, 2012-03, Vol.287 (11), p.8571-8583

2012

Volltextzugriff (PDF)

Mechanisms mediating androgen receptor reactivation after castration

Urologic oncology, 2009, Vol.27 (1), p.36-41

2009

Volltextzugriff (PDF)

Reactivation of Androgen Receptor-Regulated TMPRSS2:ERG Gene Expression in Castration-Resistant Prostate Cancer

Cancer research (Chicago, Ill.), 2009-08, Vol.69 (15), p.6027-6032

2009

Volltextzugriff (PDF)

1 – 25 von 317

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(304)
Mit Volltextzugriff
(289)

Publikationsform

Sprache

Englisch
(317)
Japanisch
(72)

Erscheinungsjahr

n.n

Thema

Science & Technology
(198)
Life Sciences & Biomedicine
(182)
Humans
(180)
Male
(135)
Animals
(82)
Oncology
(82)
Mice
(64)
Cell Line, Tumor
(55)
Biological And Medical Sciences
(54)
Prostate Cancer
(54)
Receptors, Androgen - Metabolism
(51)
Receptors, Androgen - Genetics
(48)
Medical Sciences
(44)
Prostatic Neoplasms - Genetics
(41)
Prostatic Neoplasms - Metabolism
(41)
Tumors
(36)
Prostatic Neoplasms - Pathology
(35)
Immunology
(34)
Gene Expression Regulation, Neoplastic
(31)
Prostatic Neoplasms - Drug Therapy
(30)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Adipose Tissue Invariant NKT Cells Protect against Diet-Induced Obesity and Metabolic Disorder through Regulatory Cytokine Production

Androgen Receptor Gene Expression in Prostate Cancer Is Directly Suppressed by the Androgen Receptor Through Recruitment of Lysine-Specific Demethylase 1

Intratumoral androgen biosynthesis in prostate cancer pathogenesis and response to therapy

Redirecting abiraterone metabolism to fine-tune prostate cancer anti-androgen therapy

Chromatin binding of FOXA1 is promoted by LSD1-mediated demethylation in prostate cancer

SOX9 drives WNT pathway activation in prostate cancer

Enhancer RNAs participate in androgen receptor-driven looping that selectively enhances gene activation

EZH2 Oncogenic Activity in Castration-Resistant Prostate Cancer Cells Is Polycomb-Independent

ATM Loss Confers Greater Sensitivity to ATR Inhibition than PARP Inhibition in Prostate Cancer

Rapid Induction of Androgen Receptor Splice Variants by Androgen Deprivation in Prostate Cancer

Adoptive Transfer of Invariant NKT Cells as Immunotherapy for Advanced Melanoma: A Phase I Clinical Trial

Targeting the androgen receptor and overcoming resistance in prostate cancer

WNT5a Signaling through ROR2 Activates the Hippo Pathway to Suppress YAP1 Activity and Tumor Growth

Androgen receptor and MYC equilibration centralizes on developmental super-enhancer

Expression of PD-L1 in Hormone-naïve and Treated Prostate Cancer Patients Receiving Neoadjuvant Abiraterone Acetate plus Prednisone and Leuprolide

Androgen Receptor Tumor Suppressor Function Is Mediated by Recruitment of Retinoblastoma Protein

Galeterone Prevents Androgen Receptor Binding to Chromatin and Enhances Degradation of Mutant Androgen Receptor

Role of Androgen Receptor Variants in Prostate Cancer: Report from the 2017 Mission Androgen Receptor Variants Meeting

Abiraterone treatment in castration-resistant prostate cancer selects for progesterone responsive mutant androgen receptors

Castration-resistant prostate cancer: Adaptive responses in the androgen axis

Lysine-specific demethylase 1 has dual functions as a major regulator of androgen receptor transcriptional activity

Association Between Androgen Receptor Splice Variants and Prostate Cancer Resistance to Abiraterone and Enzalutamide

Androgen Receptor Serine 81 Phosphorylation Mediates Chromatin Binding and Transcriptional Activation

Mechanisms mediating androgen receptor reactivation after castration

Reactivation of Androgen Receptor-Regulated TMPRSS2:ERG Gene Expression in Castration-Resistant Prostate Cancer

Suchergebnisse filtern